secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2022-01-27T23:59:59+00:00
Accession:  0001193125-22-019765
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q2 FY2022: Revenue $894.9M (+12% YoY), GAAP EPS $1.37, non-GAAP $1.47; dividend $0.42
--------------------------------------------------------------------------------

- Revenue $894.9M, up 12% YoY (13% constant currency); operating income $248.7M, up 12%.
- GAAP diluted EPS $1.37 (up 11%); non-GAAP diluted EPS $1.47 (up 4%).
- Gross margin contracted 140 bps GAAP to 56.4%; non-GAAP gross margin down 230 bps to 57.6%.
- Board declared quarterly cash dividend $0.42/share, payable March 17, 2022, record date Feb 10.
- CEO cited strong demand from competitor device recall, ongoing supply chain constraints.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312522019765/0001193125-22-019765-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312522019765/d477629d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-019765

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer